ZA864717B - Terguride as a geriatric agent - Google Patents
Terguride as a geriatric agentInfo
- Publication number
- ZA864717B ZA864717B ZA864717A ZA864717A ZA864717B ZA 864717 B ZA864717 B ZA 864717B ZA 864717 A ZA864717 A ZA 864717A ZA 864717 A ZA864717 A ZA 864717A ZA 864717 B ZA864717 B ZA 864717B
- Authority
- ZA
- South Africa
- Prior art keywords
- terguride
- geriatric
- agent
- geriatric agent
- doses
- Prior art date
Links
- JOAHPSVPXZTVEP-YXJHDRRASA-N Terguride Chemical compound C1=CC([C@H]2C[C@@H](CN(C)[C@@H]2C2)NC(=O)N(CC)CC)=C3C2=CNC3=C1 JOAHPSVPXZTVEP-YXJHDRRASA-N 0.000 title abstract 2
- 229960004558 terguride Drugs 0.000 title abstract 2
- 230000007812 deficiency Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Led Device Packages (AREA)
- Prostheses (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Lubricants (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19853522894 DE3522894A1 (de) | 1985-06-24 | 1985-06-24 | Verwendung von tergurid als geriatrikum |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA864717B true ZA864717B (en) | 1987-02-25 |
Family
ID=6274270
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA864717A ZA864717B (en) | 1985-06-24 | 1986-06-24 | Terguride as a geriatric agent |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4711891A (fr) |
| EP (1) | EP0207882B1 (fr) |
| JP (1) | JP2618375B2 (fr) |
| AT (1) | ATE146963T1 (fr) |
| AU (1) | AU573448B2 (fr) |
| CA (1) | CA1285880C (fr) |
| DE (2) | DE3522894A1 (fr) |
| DK (1) | DK288786A (fr) |
| IE (1) | IE80545B1 (fr) |
| IL (1) | IL79207A (fr) |
| ZA (1) | ZA864717B (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10226459A1 (de) * | 2002-06-13 | 2004-01-08 | Neurobiotec Gmbh | Verwendung von Dopamin-Partialagonisten zur Behandlung des Restless Legs Syndroms |
| EP2083008A1 (fr) * | 2007-12-07 | 2009-07-29 | Axxonis Pharma AG | Dérivés d'ergoline en tant que piégeurs radicaux sélectifs pour les neurones |
| LU92975B1 (en) * | 2016-02-09 | 2017-08-10 | Vivotecc Gmbh | Use of Lisuride and Terguride and its 2-Halogen Derivatives for the Treatment as Antipsychotics |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH573936A5 (fr) * | 1971-08-05 | 1976-03-31 | Spofa Vereinigte Pharma Werke | |
| US4323546A (en) * | 1978-05-22 | 1982-04-06 | Nuc Med Inc. | Method and composition for cancer detection in humans |
| DE3063869D1 (en) * | 1979-06-13 | 1983-07-28 | Schering Ag | (ergolin-yl)-n', n'-diethyl urea derivatives, their preparation and pharmaceutical compositions containing them |
| JPS5732281A (en) * | 1980-08-06 | 1982-02-20 | Sumitomo Chem Co Ltd | Nitrogen-containing polycyclic compound and its preparation |
| DE3101535A1 (de) * | 1981-01-14 | 1982-08-12 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Neue (2-halogen-ergolinyl)-n'.n'-diethyl-harnstoffderivate, verfahren zu ihrer herstellung und deren verwendung als arzneimittel |
| CS231214B1 (en) * | 1982-03-12 | 1984-10-15 | Antonin Cerny | Processing method of 1-substituted n+l8alpha-ergoline+p-n,diethyl urea |
| DE3309493A1 (de) * | 1983-03-14 | 1984-09-20 | Schering AG, 1000 Berlin und 4709 Bergkamen | Neue ergolin-derivate, verfahren zu ihrer herstellung sowie verwendung als arzneimittel |
| DE3410218A1 (de) * | 1984-03-16 | 1985-09-19 | Schering AG, Berlin und Bergkamen, 1000 Berlin | Tergurid als antihypertensivum |
| US4552820A (en) * | 1984-04-25 | 1985-11-12 | Lin Data Corporation | Disc media |
-
1985
- 1985-06-24 DE DE19853522894 patent/DE3522894A1/de not_active Ceased
-
1986
- 1986-06-10 US US06/872,779 patent/US4711891A/en not_active Expired - Fee Related
- 1986-06-19 DK DK288786A patent/DK288786A/da not_active Application Discontinuation
- 1986-06-20 AT AT86730096T patent/ATE146963T1/de not_active IP Right Cessation
- 1986-06-20 EP EP86730096A patent/EP0207882B1/fr not_active Expired - Lifetime
- 1986-06-20 DE DE3650590T patent/DE3650590D1/de not_active Expired - Lifetime
- 1986-06-23 CA CA000512215A patent/CA1285880C/fr not_active Expired - Lifetime
- 1986-06-23 JP JP61145028A patent/JP2618375B2/ja not_active Expired - Lifetime
- 1986-06-23 AU AU59206/86A patent/AU573448B2/en not_active Ceased
- 1986-06-23 IE IE166386A patent/IE80545B1/en not_active IP Right Cessation
- 1986-06-24 IL IL79207A patent/IL79207A/xx not_active IP Right Cessation
- 1986-06-24 ZA ZA864717A patent/ZA864717B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK288786D0 (da) | 1986-06-19 |
| IL79207A0 (en) | 1986-09-30 |
| DK288786A (da) | 1986-12-25 |
| DE3650590D1 (de) | 1997-02-13 |
| EP0207882A2 (fr) | 1987-01-07 |
| AU5920686A (en) | 1987-01-08 |
| US4711891A (en) | 1987-12-08 |
| IE80545B1 (en) | 1998-09-09 |
| IL79207A (en) | 1993-04-04 |
| IE861663L (en) | 1986-12-24 |
| EP0207882B1 (fr) | 1997-01-02 |
| JPS6259211A (ja) | 1987-03-14 |
| DE3522894A1 (de) | 1987-01-02 |
| EP0207882A3 (fr) | 1990-01-31 |
| ATE146963T1 (de) | 1997-01-15 |
| JP2618375B2 (ja) | 1997-06-11 |
| AU573448B2 (en) | 1988-06-09 |
| CA1285880C (fr) | 1991-07-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3760201D1 (en) | (-)-benzhydrylsulfinylacetamide, process for its preparation and its use in therapy | |
| AU585775B2 (en) | Self controlled release device for administering beneficial agent to recipient | |
| IE882960L (en) | Osmotic dosage form for administering isradipine | |
| SE8504720D0 (sv) | New drug preparation | |
| GB8629567D0 (en) | Therapeutic agents | |
| ZA853697B (en) | Derivatives of glycerophosphocholine and glycerophospho-ethanolamine,their preparation and their use | |
| IL87089A0 (en) | N-aminobutyl-n-phenylarylamide derivatives,their preparation and their application in therapy | |
| IL79853A0 (en) | Azolyl-cyclopropyl-ethanol derivatives,processes for their preparation and their use | |
| GR900300044T1 (en) | Use of monosubstitute selenium compounds in the preparation of a pharmaceutical, pharmaceutical and preparation thereof | |
| DE3572489D1 (en) | Indolophenanthridines, their preparation and use | |
| DE3660204D1 (en) | Process for the preparation of dichlorotrifluoroethoxy and ethylthioaromatic derivatives | |
| IL79207A0 (en) | Pharmaceutical compositions containing terguide | |
| EP0147707A3 (en) | 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases | |
| JPS57181072A (en) | Oxaprodine derivative | |
| AU7071487A (en) | Chlorpheniramine therapy | |
| EP0199085A3 (en) | Jomol, its derivatives, process for the preparation of these substances, their use and their production | |
| ZA871130B (en) | Salt of a substituted morpholine with fluoboric acid and wood preservatives | |
| AU2192783A (en) | 3:,5:-diarabinosides preparation and application in therapy | |
| GR3015373T3 (en) | 2-Halogen-substituted N-indolyl sulfonic-acid amides, process for their preparation and their pharmaceutical use. | |
| IL98200A0 (en) | Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide | |
| GR3002328T3 (en) | 2-(benzhydrylsulfonyl) acetamide, process for its preparation and its therapeutical use | |
| ZA876485B (en) | 5-aminoethyloxazolidin-2-one derivatives,process for the preparation thereof and their therapeutic use | |
| GB2213062A (en) | Pharmaceutical preparation having oestrogen action | |
| PT80796A (en) | Process for the preparation of solutions of beclometasone 17,21-diprophionate in ether and use thereof | |
| ZA853779B (en) | The novel physiologically active substance foroxymithine,a process and microorganisms for its production and its use as medicament |